A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy
暂无分享,去创建一个
T Deirdre Hollingsworth | Ard van Sighem | Christophe Fraser | Ronald B Geskus | Maria Prins | Frank de Wolf | Daniela Bezemer | Roel A Coutinho | C. Fraser | T. Hollingsworth | R. Geskus | M. Boerlijst | M. Prins | F. de Wolf | A. van Sighem | R. Coutinho | D. Bezemer | Luuk Gras | Maarten C Boerlijst | L. Gras
[1] M. Prins,et al. Condom Use Rather Than Serosorting Explains Differences in HIV Incidence Among Men Who Have Sex With Men , 2007, Journal of acquired immune deficiency syndromes.
[2] Neil M Ferguson,et al. The epidemiological impact of antiretroviral use predicted by mathematical models: a review , 2005, Emerging themes in epidemiology.
[3] Mark A van de Wiel,et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy , 2003, AIDS.
[4] M. Hirsch,et al. Prevalence and predictive value of intermittent viremia with combination hiv therapy. , 2001, JAMA.
[5] Phalguni Gupta,et al. Adherence to Antiretroviral Therapy and Persistence of HIV RNA in Semen , 2003, Journal of acquired immune deficiency syndromes.
[6] S. Vermund,et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.
[7] I. Stolte,et al. Increase of sexually transmitted infections, but not HIV, among young homosexual men in Amsterdam: are STIs still reliable markers for HIV transmission? , 2005, Sexually Transmitted Infections.
[8] Steven Gibson,et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. , 2002, American journal of public health.
[9] Mirjam Kretzschmar,et al. The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam , 2003, AIDS.
[10] H. Gershengorn,et al. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? , 2002, The Lancet. Infectious diseases.
[11] O. Laeyendecker,et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.
[12] M. Dijkgraaf,et al. AIDS scenarios for The Netherlands; the economic impact on hospitals. , 1995, Health policy.
[13] M. Law,et al. Modeling Trends in HIV Incidence Among Homosexual Men in Australia 1995–2006 , 2004, Journal of acquired immune deficiency syndromes.
[14] E. De Clercq,et al. Managing resistance to anti-HIV drugs: an important consideration for effective disease management. , 1999, Drugs.
[15] William C Miller,et al. Detection of acute infections during HIV testing in North Carolina. , 2005, The New England journal of medicine.
[16] S. Kippax,et al. Modelling the effect of combination antiretroviral treatments on HIV incidence , 2001, AIDS.
[17] M. S. Sánchez,et al. HIV Drug-resistant Strains as Epidemiologic Sentinels , 2006, Emerging infectious diseases.
[18] P. Kaye. Infectious diseases of humans: Dynamics and control , 1993 .
[19] P. Vernazza,et al. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] HOMAS,et al. VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .
[21] S. Hammer,et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. , 1996, The New England journal of medicine.
[22] C. Fraser. Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic , 2007, PloS one.
[23] J. Dilley,et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? , 2006, Sexually Transmitted Infections.
[24] Prabhat Jha,et al. Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. , 2002, Bulletin of the World Health Organization.
[25] I. Stolte,et al. Low HIV-testing rates among younger high-risk homosexual men in Amsterdam , 2007, Sexually Transmitted Infections.
[26] Gary Marks,et al. Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States: Implications for HIV Prevention Programs , 2005, Journal of acquired immune deficiency syndromes.
[27] R. Geskus,et al. Declining AIDS Mortality in Amsterdam: Contributions of Declining HIV Incidence and Effective Therapy , 2004, Epidemiology.
[28] J. Goudsmit,et al. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. , 1987, American journal of epidemiology.
[29] B. Berkhout,et al. Declining trend in transmission of drug-resistant HIV-1 in Amsterdam , 2004, AIDS.
[30] Ronald B Geskus,et al. HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984–2005 , 2007, AIDS.
[31] R. Geskus,et al. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study , 2004, AIDS.
[32] V. Cejka,et al. [Kaposi's sarcoma and fatal opportunistic infections in a homosexual man with immunodeficiency]. , 1983, Nederlands tijdschrift voor geneeskunde.
[33] M. Boerlijst,et al. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains , 2001, AIDS.
[34] H. Gershengorn,et al. A tale of two futures: HIV and antiretroviral therapy in San Francisco. , 2000, Science.
[35] G. Garnett,et al. Is HIV out of control in the UK? An example of analysing patterns of HIV spreading using incidence-to-prevalence ratios , 2006, AIDS.
[36] L. Kingsley,et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors , 1997, Journal of virology.